Costs Over Damages Doesn’t Equal Exceptional
What makes a case exceptional? In the matter of ATEN International Co., LTD. v. Uniclass Technology Co., LTD. before the US Court of Appeals for the Central District of California, it was a
[Read More]What makes a case exceptional? In the matter of ATEN International Co., LTD. v. Uniclass Technology Co., LTD. before the US Court of Appeals for the Central District of California, it was a
[Read More]You may remember when Harley-Davidson famously tried for years to trademark the sound of their V-twin motorcycle engine. The process was held up in legal limbo for so long that they ended up
[Read More]A step-by-step visual guide to an important part of the legal process.
[Read More]When a computer scientist named Jarek Duda contacted Ars Technica claiming that Google was attempting to patent a technique he put into the public domain, the publication investigated it and found the company’s
[Read More]In May, we posted about the Constitutionality of IPRs after the Supreme Court upheld the United States Patent and Trademark Office’s inter partes review process, ruling that it doesn’t violate Article III of
[Read More]Earlier this year, we caught up on the amended rules in the Eastern District of Texas. In that post, and for the year ahead, we included a refresh on the important venue case
[Read More]Last fall, we blogged that the inter partes review was celebrating its fifth anniversary and would soon be under scrutiny when the Supreme Court heard Oil States Energy Services v. Greene’s Energy Group.
[Read More]If you’re general counsel for a life sciences company, you’re probably aware that 2017 was a record year for class action securities litigation, in particular targeting your industry. According to a highly in-depth
[Read More]We kicked off 2018 with a post on the Eastern District of Texas’ amended rules. In that post, we revisited TC Heartland and its potential impact in the new year. We continue the
[Read More]One of the more popular topics we post on is patents. In 2017, we wrote about the eye-opening practice of companies warding off future challenges to their patents by shielding themselves with Native
[Read More]For many, November and December 2017 were a blur. In case you missed the Eastern District of Texas’ amended rules, we highlight a few below. The amended rules can be read in full
[Read More]Last month, we dipped into the eye-opening matter of companies warding off future challenges to their patents by shielding themselves with Native American tribes’ sovereign immunity. Specifically, a partnership between the drug company
[Read More]We'll keep your email safe. No spam, we promise!